Related Experiment Videos
[Neurotrophic factors: basis for their clinical application]
1Seccion de Neurología, Hospital Alvarez-Buylla, Mieres, Austrias. gmorist@seneurologia.org
Neurologia (Barcelona, Spain)
|February 19, 2003
Summary
Neurotrophic factors regulate neuronal survival and plasticity, showing potential for treating neurodegenerative diseases like Alzheimer's and Parkinson's. Challenges remain in delivering these factors to the central nervous system for effective therapy.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Context:
- Neurotrophic factors are crucial for neuronal survival, plasticity, and function.
- These molecules play a role in the development of neurodegenerative disorders.
- Existing research explores their therapeutic potential in preclinical models.
Purpose:
- To review the essential aspects of neurotrophic factors.
- To discuss their clinical relevance and therapeutic potential in neurodegenerative diseases.
- To highlight challenges and future research directions.
Summary:
- Key neurotrophic factor families include neurotrophins (NGF, BDNF, NT-3), GDNF, CNTF, and IGFs.
- Despite promising preclinical data, clinical trials have yielded mixed results.
- Delivery to the central nervous system is a significant hurdle for therapeutic application.
Impact:
- Neurotrophic factors offer a rational basis for treating Alzheimer's, Parkinson's, peripheral neuropathies, and ALS.
- Further research is needed to overcome delivery challenges and optimize clinical efficacy.
- This review provides a comprehensive overview for researchers and clinicians in the field.